P

Inventor

MAERKI HANS P

CH41 patents
⚠️ This page may combine multiple inventors who share the name “MAERKI HANS P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

30 patents
US5278148AJan 11, 1994

Amino acid derivatives useful for treating high blood pressure

HOFFMANN LA ROCHE102 citations96
US5521160AMay 28, 1996

Sulfuric acid esters of sugar alcohols

HOFFMANN LA ROCHE30 citations90
US5376674ADec 27, 1994

Oxetanone compounds containing proline and pharmaceutical compositions thereof

HOFFMANN LA ROCHE22 citations89
US7935707B2May 3, 2011

Imidazole derivatives

HOFFMANN LA ROCHE9 citations84
US7754744B2Jul 13, 2010

Substituted piperidinamines as somatostatin receptor subtype 5 (SSTR5) antagonists

HOFFMANN LA ROCHE11 citations83
US5466708ANov 14, 1995

Oxetanones

HOFFMANN LA ROCHE14 citations81
US5260310ANov 9, 1993

Oxetanone compounds and pharmaceutical compositions containing them

HOFFMANN LA ROCHE17 citations81
US5140011AAug 18, 1992

Amino acid derivatives which have renin inhibiting activity

HOFFMANN LA ROCHE11 citations74
US9695151B2Jul 4, 2017

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

HOFFMANN LA ROCHE6 citations73
US9695152B2Jul 4, 2017

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

HOFFMANN LA ROCHE6 citations73
US10428108B2Oct 1, 2019

Difluoroketamide derivatives

HOFFMANN LA ROCHE5 citations72
US9980929B2May 29, 2018

Trifluoromethylpropanamide derivatives

HOFFMANN LA ROCHE5 citations72
US9505742B2Nov 29, 2016

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

HOFFMANN LA ROCHE4 citations72
US9187429B2Nov 17, 2015

Phenyl-tetrahydroisoquinoline derivatives

HOFFMANN LA ROCHE2 citations62
US7977358B2Jul 12, 2011

Pyrazol derivatives

HOFFMANN LA ROCHE3 citations62
US11001555B2May 11, 2021

Difluoroketamide derivatives as HTRA1 inhibitors

HOFFMANN LA ROCHE0 citations52
US11059858B2Jul 13, 2021

Difluoroketamide derivatives as HtrA1 inhibitors

HOFFMANN LA ROCHE0 citations51
US11014963B2May 25, 2021

Trifluoromethylpropanamide derivatives as HTRA1 inhibitors

HOFFMANN LA ROCHE0 citations51
US8026255B2Sep 27, 2011

Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists

HOFFMANN LA ROCHE1 citations51
US10865182B2Dec 15, 2020

Difluoroketamide derivatives as HtrA1 inhibitors

HOFFMANN LA ROCHE0 citations41
US9796702B2Oct 24, 2017

Dihydroquinoline pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9796726B2Oct 24, 2017

Dihydroquinoline pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9790200B2Oct 17, 2017

Dihydroquinoline pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9790217B2Oct 17, 2017

Pyridinyloxy- and phenyloxy-pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9636339B2May 2, 2017

Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors

HOFFMANN LA ROCHE0 citations41
US9636338B2May 2, 2017

Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase

HOFFMANN LA ROCHE0 citations41
US9593107B2Mar 14, 2017

Dihydroquinoline-2-one derivatives

HOFFMANN LA ROCHE0 citations41
US9464058B2Oct 11, 2016

Imidazolylketone derivatives

HOFFMANN LA ROCHE0 citations41
US9458135B2Oct 4, 2016

Dihydroquinoline-2-one derivatives

HOFFMANN LA ROCHE0 citations41
US9133158B2Sep 15, 2015

Bicyclic dihydroisoquinoline-1-one derivatives

HOFFMANN LA ROCHE0 citations41

AEBI JOHANNES

9 patents

ADAM JEAN-MICHEL

2 patents